Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin

American Journal of Clinical Nutrition

Volumn 85, Issue 4, 2007, Pages 967-971

  Germain, Natacha ^a   Galusca, Bogdan ^a   Le Roux, Carel W ^b   Bossu, Cecile ^a   Ghatei, Mohammad A ^b   Lang, Francois ^a   Bloom, Stephen R ^b   Estour, Bruno ^a,c  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c SERVICE DE NEUROLOGIE   (France)

Author keywords

Anorexia nervosa; Constitutional thinness; Ghrelin; Glucagon like peptide 1; Leptin; Peptide YY

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1; LEPTIN; PEPTIDE YY;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LEAN BODY WEIGHT;

EID: 34147153752     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.4.967     Document Type: Article

References (39)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60.
2. Cummings DE, Frayo RS, Marmonier C, Aubert R, Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 2004;287:E297-304.
3. Greeley GH Jr, Jeng YJ, Gomez G, et al. Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology 1989;124:1438-43.
4. Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002;418:650-4.
5. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987;2:1300-4.
6. Schirra J, Goke B. The physiological role of GLP-1 in human: incretin, ileal brake or more? Regul Pept 2005;128:109-15.
7. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996;98:1101-6.
8. Soriano-Guillen L, Barrios V, Campos-Barros A, Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 2004;144:36-42.
9. Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001;145:669-73.
10. Tolle V, Kadem M, Bluet-Pajot MT, et al. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab 2003;88:109-16.
11. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623-30.
12. Alvarez Bartolome M, Borque M, Martinez-Sarmiento J, et al. Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty. Obes Surg 2002;12:324-7.
13. Gendall KA, Kaye WH, Altemus M, McConaha CW, La Via MC. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry 1999;46:292-9.
14. Stock S, Leichner P, Wong AC, et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 2005;90:2161-8.
15. Misra M, Miller KK, Tsai P, et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006;91:1027-33.
16. Tomasik PJ, Sztefko K, Malek A. GLP-1 as a satiety factor in children with eating disorders. Horm Metab Res 2002;34:77-80.
17. Grinspoon S, Gulick T, Askari H, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 1996;81:3861-3.
18. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.
19. Fisher M, Golden NH, Katzman DK, et al. Eating disorders in adolescents: a background paper. J Adolesc Health 1995;16:420-37.
20. Schneider L, Heard I, Breart G, Henrion R. [Maternal thinness and pregnancy]. Arch Fr Pediatr 1979;36:1068-74 (in French).
21. Paggi A, Di Giovanni N, Natoli A. [Study of thyroid function in constitutionally thin subjects]. Boll Soc Ital Biol Sper 1975;51:1-4 (in Italian).
22. Tagami T, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2004;89:1833-7.
23. Bulik CM, Allison DB. The genetic epidemiology of thinness. Obes Rev 2001;2:107-15.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
25. Le Moullec N, Deheeger M, Preziosi P, et al. Validation du manuel photos utilisé pour l'enquête alimentaire de l'Etude SU. VI.MAX. [Validation of the photo manual used for the collection of dietary data in the SU.VI.MAX Study.] Cah Nutr Diet 1996;31:158-64 (in French).
26. Bertrais S, Galan P, Renault N, Zarebska M, Preziosi P, Hercberg S. Consumption of soup and nutritional intake in French adults: consequences for nutritional status. J Hum Nutr Diet 2001;14:121-8.
27. Fuller NJ, Jebb SA, Laskey MA, Coward WA, Elia M. Four-component model for the assessment of body composition in humans: comparison with alternative methods, and evaluation of the density and hydration of fat-free mass. Clin Sci (Lond) 1992;82:687-93.
28. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990;51:1106-12.
29. Bossu C, Galusca B, Normand S, et al. Energy expenditure adjusted for body composition differentiates constitutional thinness from both normal subjects and anorexia nervosa. Am J Physiol Endocrinol Metab 2007;292:E132-7.
30. Feinle-Bisset C, Patterson M, Ghatei MA, Bloom SR, Horowitz M. Fat digestion is required for the suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid. Am J Physiol Endocrinol Metab 2005;289:E948-53.
31. Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003;349:941-8.
32. Bacha F, Arslanian SA. Ghrelin and peptide YY in youth: are there race-related differences? J Clin Endocrinol Metab 2006;91:3117-22.
33. Wortley KE, del Rincon JP, Murray JD, et al. Absence of ghrelin protects against early-onset obesity. J Clin Invest 2005;115:3573-8.
34. Baggio LL, Huang Q, Brown TJ, Drucker DJ. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 2004;127:546-58.
35. De Souza MJ, Leidy HJ, O'Donnell E, Lasley B, Williams NI. Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. J Clin Endocrinol Metab 2004;89:3536-42.
36. Holtkamp K, Mika C, Grzella I, et al. Reproductive function during weight gain in anorexia nervosa. Leptin represents a metabolic gate to gonadotropin secretion. J Neural Transm 2003;110:427-35.
37. Norman RL. Corticotropin-releasing hormone effects on luteinizing hormone and cortisol secretion in intact female rhesus macaques. Biol Reprod 1994;50:949-55.
38. Mitchell JE, Cook-Myers T, Wonderlich SA. Diagnostic criteria for anorexia nervosa: looking ahead to DSM-V. Int J Eat Disord 2005;37(suppl):S95-7.
39. Chanoine JP. Editorial: individual differences in the hormonal control of appetite: a step toward a (more) successful treatment of childhood overweight? J Clin Endocrinol Metab 2006;91:2864-6.